Development of a Novel SARS-CoV-2 Immune Complex Vaccine Candidate (CRCx) with Broad Immune Responses: A Preclinical Trial in Animal Model
K. M. El Sayed Zayed, S. S. Abdulaziz, K. O. Abdallah
This paper evaluates two SARS-CoV-2 vaccine candidates, CRCx2 and CRCx3, in mice, showing they induce neutralizing antibodies and cellular immune responses with high protection and therapeutic potential.
bioRxiv · May 27, 2022 · PreprintImmunology